{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:21:59Z","timestamp":1774084919241,"version":"3.50.1"},"reference-count":82,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1586\/14787210.2014.945432","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T02:23:56Z","timestamp":1407291836000},"page":"1179-1186","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection"],"prefix":"10.1586","volume":"12","author":[{"given":"Ivan","family":"Gentile","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u2018Federico II\u2019,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Riccardo","family":"Buonomo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u2018Federico II\u2019,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Zappulo","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u2018Federico II\u2019,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Coppola","sequence":"additional","affiliation":[{"name":"Department of Mental Health and Public Medicine, Section of Infectious diseases, Second University of Naples,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guglielmo","family":"Borgia","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u2018Federico II\u2019,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03432.x"},{"key":"e_1_3_4_3_1","unstructured":"Hepatitis C. WHO. 2014. Available from: www.who.int\/mediacentre\/factsheets\/fs164\/en\/ [Last accessed 2 July 2014]"},{"issue":"10","key":"e_1_3_4_4_1","first-page":"318","article-title":"Expanded classification of hepatitis C Virus into 7 genotypes and 67 subtypes: updated criteria and assignment web resource","volume":"1","author":"Smith DB","year":"2013","unstructured":"Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C Virus into 7 genotypes and 67 subtypes: updated criteria and assignment web resource. Hepatology 2013;1(10):318-27","journal-title":"Hepatology"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2012.09.009"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.03.025"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30900-7"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.8352"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2007.0049"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.9.1696"},{"issue":"6","key":"e_1_3_4_11_1","first-page":"773","article-title":"Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection","volume":"27","author":"Gentile I","year":"2013","unstructured":"Gentile I, Meola M, Buonomo AR, et al. Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection. In vivo 2013;27(6):773-7","journal-title":"In vivo"},{"issue":"10","key":"e_1_3_4_12_1","first-page":"17","article-title":"Metabolic factors and chronic hepatitis C: a complex interplay","volume":"564645","author":"Macaluso FS","year":"2013","unstructured":"Macaluso FS, Maida M, Minissale MG, et al. Metabolic factors and chronic hepatitis C: a complex interplay. Biomed Res Int 2013;564645(10):17","journal-title":"Biomed Res Int"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.069"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-003-3131-4"},{"issue":"1","key":"e_1_3_4_15_1","first-page":"11","article-title":"Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters?","volume":"22","author":"Gentile I","year":"2014","unstructured":"Gentile I, Buonomo AR, Zappulo E, Borgia G. Is it possible to predict HCV-related liver cirrhosis non-invasively through routine laboratory parameters? Infez Med 2014;22(1):11-18","journal-title":"Infez Med"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318157464b"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.067"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04370.x"},{"issue":"4","key":"e_1_3_4_19_1","first-page":"e305","article-title":"HCV-related autoimmune disorders in HCV chronic infection","volume":"164","author":"Ferrari SM","year":"2013","unstructured":"Ferrari SM, Fallahi P, Mancusi C, et al. HCV-related autoimmune disorders in HCV chronic infection. Clin Ter 2013;164(4):e305-12","journal-title":"Clin Ter"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.07.016"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12053"},{"key":"e_1_3_4_22_1","first-page":"S1386","article-title":"Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells","author":"Coppola N","year":"2013","unstructured":"Coppola N, Pascalis SD, Pisaturo M, et al. Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells. J Clin Virol 2013;S1386-653","journal-title":"J Clin Virol"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.850073"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260431"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20313"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.10.014"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000348506"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26245"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.08.009"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2007.07.005"},{"issue":"4","key":"e_1_3_4_31_1","first-page":"527","article-title":"Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report","volume":"27","author":"Gentile I","year":"2013","unstructured":"Gentile I, De Stefano A, Di Flumeri G, et al. Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report. In vivo 2013;27(4):527-9","journal-title":"In vivo"},{"issue":"1","key":"e_1_3_4_32_1","first-page":"83","article-title":"Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy","volume":"65","author":"Gentile I","year":"2013","unstructured":"Gentile I, Di Flumeri G, Scarica S, et al. Acute hepatitis C in patients undergoing hemodialysis: experience with high-dose interferon therapy. Minerva Urol Nefrol 2013;65(1):83-4","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.023"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i42.5648"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20190"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21492"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.020"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013376"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.8404"},{"issue":"14","key":"e_1_3_4_40_1","first-page":"00372","article-title":"Pegylated interferon alpha plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency","volume":"27","author":"Rosina F","year":"2014","unstructured":"Rosina F, Tosti ME, Borghesio E, et al. Pegylated interferon alpha plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. Dig Liver Dis 2014;27(14):00372-7","journal-title":"Dig Liver Dis"},{"key":"e_1_3_4_41_1","unstructured":"Recommendations for testing managing and treating hepatitis C. AASLD IDSA. 2014. Available from: www.hcvguidelines.org\/fullreport [Last accessed 4 July 2014]"},{"key":"e_1_3_4_42_1","unstructured":"EASL Recommendations on Treatment of Hepatitis C. EASL. 2014. Available from: http:\/\/files.easl.eu\/easl-recommendations-on-treatment-of-hepatitis-C.pdf [Last accessed 4 July 2014]"},{"key":"e_1_3_4_43_1","unstructured":"European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C. Agency EM. 2013. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2013\/11\/WC500155469.pdf [Last accessed 1 February 2014]"},{"key":"e_1_3_4_44_1","unstructured":"Approval of Sovaldi (sofosbuvir) tablets for the treatment of chronic hepatitis C. FDA. 2014. Available from: www.fda.gov\/forconsumers\/byaudience\/forpatientadvocates\/ucm377920.htm [Last accessed 4 July 2014]"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i18.2793"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.039"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.08.036"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8229.108182"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01832.x"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0106-9543.2002.01672.x"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20210"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i47.5184"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i8.800"},{"key":"e_1_3_4_54_1","first-page":"1","article-title":"Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV\/HCV dual infection","volume":"1","author":"Coppola N","year":"2013","unstructured":"Coppola N, Marrone A, Pisaturo M, et al. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV\/HCV dual infection. Eur J Clin Microbiol Infect Dis 2013;1:1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24641"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22759"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1089\/10799900360520405"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1089\/10799900152434321"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2005.25.283"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-007-0259-1"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2174\/09298673113209990178"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(12)60010-5"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666131228222215"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.892581"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S66731"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.921680"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574887109666140529222602"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.929497"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3248"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986709787581789"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903501505"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.019"},{"issue":"8","key":"e_1_3_4_73_1","first-page":"614","article-title":"Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections","volume":"8","author":"Beaulieu PL","year":"2007","unstructured":"Beaulieu PL. Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections. Curr Opin Investig Drugs 2007;8(8):614-34","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2013.795543"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401420j"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02052-12"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(12)61201-X"},{"key":"e_1_3_4_78_1","first-page":"1072A","article-title":"Lack of a clinically significant pharmacokinetic drug-drug interaction between sofosbuvir (GS-7977) and GS-5885 or GS-9669 in Healthy Volunteers","volume":"56","author":"German P","year":"2012","unstructured":"German P, Mathias A, Pang PS, et al. Lack of a clinically significant pharmacokinetic drug-drug interaction between sofosbuvir (GS-7977) and GS-5885 or GS-9669 in Healthy Volunteers. Hepatology 2012;56:1072A-3A","journal-title":"Hepatology"},{"key":"e_1_3_4_79_1","unstructured":"Kohli A SZ Marti M et al. editor. Combination oral ribavirin free antiviral therapy to optimize treatment outcomes for hepatitis C GT-1 treatment naive patients: interim results from the NIAID SYNERGY Trial. 64th Annual Meeting of the American Association for the Study of Liver Diseases; Washington DC; 2013"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.11.007"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(13)61194-0"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2014.920254"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i34.4677"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14787210.2014.945432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:45:51Z","timestamp":1770414351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14787210.2014.945432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":82,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1586\/14787210.2014.945432"],"URL":"https:\/\/doi.org\/10.1586\/14787210.2014.945432","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}